UK Accelerates Clinical Trials, Slashing Set-Up Time to Boost Patient Access
Government-backed reforms and Euro 137 million investment cut trial start times significantly, enabling faster access to innovative treatments through the National Health Service.
Patient Access | 17/04/2026 | By News Bureau
Clinigen and Essential Pharma to Improve Patient Access in JAPAC
IOPIDINE 5mg/ml is a short-term adjunctive therapy for patients with chronic glaucoma on maximally tolerated medical therapy to prevent or control intraocular pressure.
Patient Access | 14/02/2025 | By Aishwarya | 548
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy